Pricing Log in Create free account
Saturday 17 October 2026 Export IDXX’s income statement to Excel — free account

IDEXX Laboratories, Inc.

IDXX Healthcare Diagnostics & Research

IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.66%, EPS grew 17.2%, free cash flow grew 111.4% and total debt fell 14.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years, operating cash flow growth for three.

560.36 13.18 +2.41%
Market cap
$43.1B
P/E
39.1×
Fwd P/E
38.3×
Dividend yield
—
F-score
8/9
Altman Z
24.09
Beneish M
−2.50
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

IDEXX Laboratories, Inc. (IDXX) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, IDEXX Laboratories, Inc. (IDXX) trades at a P/S ratio of 9.7×. Over the past ten years it has ranged from 3.7× (January 2016) to 19.8× (August 2021); the current reading is higher than 49% of that period. That is above the Diagnostics & Research industry median of 4.4× and above the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 12.6× 44.52%
FY2024 8.7× (29.61%)
FY2023 12.4× 23.25%
FY2022 10.1× (42.21%)
FY2021 17.4× 10.70%
FY2020 15.8× 68.70%
FY2019 9.3× 27.97%
FY2018 7.3× 3.79%
FY2017 7.0× 18.35%
FY2016 5.9× 41.00%

Quarterly newest first

Period P/S ratio Change
Jun 2026 9.1× (9.31%)
Mar 2026 10.1× (20.38%)
Dec 2025 12.6× 2.96%
Sep 2025 12.3× 14.96%
42 more quarters

Against its own ten years

Low 3.7× High 19.8×
Ten-year median 9.8×
Current reading's percentile 44

P/S ratio against peers

Company P/S ratio
LH Labcorp Holdings Inc. compare 1.8×
DGX Quest Diagnostics Incorporated compare 2.3×
IQV IQVIA Holdings Inc. compare 2.6×
A Agilent Technologies, Inc. compare 6.6×
MTD Mettler-Toledo International, Inc. compare 7.9×
ILMN Illumina, Inc. compare 8.8×
WAT Waters Corporation compare 9.2×
IDXX IDEXX Laboratories, Inc. 9.7×
NTRA Natera, Inc. compare 20.7×
Diagnostics & Research industry median 4.4×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on IDXX